A PHASE 2 STUDY OF TRASTUZUMAB EMTANSINE IN JAPANESE PATIENTS WITH HER2 POSITIVE METASTATIC BREAST CANCER

被引：0

作者：

Takahashi, S.

Kashiwaba, M. ^{[1
]}

Takao, S. ^{[2
]}

Ito, Y.

Doihara, H. ^{[3
]}

Rai, Y.

Matsubara, M.

Kanatani, K.

Masuda, N. ^{[4
]}

机构：

[1] Iwate Med Univ, Morioka, Iwate, Japan

[2] Hyogo Canc Ctr, Kobe, Hyogo, Japan

[3] Okayama Univ Hosp, Okayama, Japan

[4] NHO Osaka Natl Hosp, Osaka, Japan

来源：

ANNALS OF ONCOLOGY | 2013年 / 24卷

关键词：

D O I：

10.1093/annonc/mdt448

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：20 / 20

页数：1

共 50 条

[41] FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer [J].

Amiri-Kordestani, Laleh ;

Blumenthal, Gideon M. ;

Xu, Qiang Casey ;

Zhang, Lijun ;

Tang, Shenghui W. ;

Ha, Linan ;

Weinberg, Wendy C. ;

Chi, Bo ;

Candau-Chacon, Reyes ;

Hughes, Patricia ;

Russell, Anne M. ;

Miksinski, Sarah Pope ;

Chen, Xiao Hong ;

McGuinn, W. David ;

Palmby, Todd ;

Schrieber, Sarah J. ;

Liu, Qi ;

Wang, Jian ;

Song, Pengfei ;

Mehrotra, Nitin ;

Skarupa, Lisa ;

Clouse, Kathleen ;

Al-Hakim, Ali ;

Sridhara, Rajeshwari ;

Ibrahim, Amna ;

Justice, Robert ;

Pazdur, Richard ;

Cortazar, Patricia .

CLINICAL CANCER RESEARCH, 2014, 20 (17) :4436-4441

[42] Trastuzumab emtansine (Kadcyla®) approval in HER2-positive metastatic breast cancers [J].

Guerin, Mathilde ;

Sabatier, Renaud ;

Goncalves, Anthony .

BULLETIN DU CANCER, 2015, 102 (04) :390-397

[43] Trastuzumab emtansine in HER2-positive metastatic breast cancer after pertuzumab and trastuzumab: TDM1RM Study [J].

Martinez-Garcia, J. ;

Puertes Boix, A. ;

Sanchez Henarejos, P. ;

Jimenez Lucas, M. D. ;

Sanchez Saura, A. ;

Luengo, M. ;

Carrillo Vicente, R. ;

Martinez Ortiz, M. J. ;

Balsalobre, J. ;

de la Morena Barrio, P. D. L. M. ;

Garcia Garre, E. ;

Garcia, E. ;

Marin, G. ;

Garcia Torralba, E. ;

Ayala de la Pena, F. ;

Collado, D. ;

Lopez, A. ;

Quiros, T. ;

Sanchez, D. A. ;

Romero, J. L. A. .

ANNALS OF ONCOLOGY, 2020, 31 :S358-S358

[44] A phase 1b study of S-1 combined with trastuzumab emtansine (T-DM1) for HER2 positive metastatic breast cancer [J].

Kojima, Yasuyuki ;

Yoshie, Reiko ;

Kawamoto, Hisanori ;

Shimo, Arata ;

Uejima, Tomoko ;

Iwatani, Tsuguo ;

Motoyoshi, Ai ;

Haku, Ei ;

Kanemaki, Yoshihide ;

Tsugawa, Koichiro .

ANNALS OF ONCOLOGY, 2018, 29

[45] A multicenter Phase II study evaluating the efficacy, safety and pharmacokinetics of trastuzumab emtansine in Japanese patients with heavily pretreated HER2-positive locally recurrent or metastatic breast cancer [J].

Kashiwaba, Masahiro ;

Ito, Yoshinori ;

Takao, Shintaro ;

Doihara, Hiroyoshi ;

Rai, Yoshiaki ;

Kanatani, Kazumitsu ;

Takashima, Shigemitsu ;

Masuda, Norikazu .

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (05) :407-414

[46] Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer [J].

von Minckwitz, G. ;

Huang, C. -S. ;

Mano, M. S. ;

Loibl, S. ;

Mamounas, E. P. ;

Untch, M. ;

Wolmark, N. ;

Rastogi, P. ;

Schneeweiss, A. ;

Redondo, A. ;

Fischer, H. H. ;

Jacot, W. ;

Conlin, A. K. ;

Arce-Salinas, C. ;

Wapnir, I. L. ;

Jackisch, C. ;

DiGiovanna, M. P. ;

Fasching, P. A. ;

Crown, J. P. ;

Wuelfing, P. ;

Shao, Z. ;

Caremoli, E. Rota ;

Wu, H. ;

Lam, L. H. ;

Tesarowski, D. ;

Smitt, M. ;

Douthwaite, H. ;

Singel, S. M. ;

Geyer, C. E., Jr. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (07) :617-628

[47] Role of trastuzumab emtansine in the treatment of HER2-positive breast cancer [J].

Oostra, Drew R. ;

Macrae, Erin R. .

BREAST CANCER-TARGETS AND THERAPY, 2014, 6 :103-113

[48] Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer [J].

Geyer, Charles E. ;

Untch, Michael ;

Huang, Chiun-Sheng ;

Mano, Max S. ;

Mamounas, Eleftherios P. ;

Wolmark, Norman ;

Rastogi, Priya ;

Schneeweiss, Andreas ;

Redondo, Andres ;

Fischer, Hans H. ;

D'Hondt, Veronique ;

Conlin, Alison K. ;

Guarneri, Valentina ;

Wapnir, Irene L. ;

Jackisch, Christian ;

Arce-Salinas, Claudia ;

Fasching, Peter A. ;

DiGiovanna, Michael P. ;

Crown, John P. ;

Wuelfing, Pia ;

Shao, Zhimin ;

Caremoli, Elena Rota ;

Bonnefoi, Herve R. ;

Hennessy, Bryan T. ;

Stamatovic, Ljiljana ;

Castro-Salguero, Hugo ;

Brufsky, Adam M. ;

Knott, Adam ;

Siddiqui, Asna ;

Lambertini, Chiara ;

Boulet, Thomas ;

Nyawira, Beatrice ;

Restuccia, Eleonora ;

Loibl, Sibylle .

NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (03) :249-257

[49] Trastuzumab and vinorelbine combination in the treatment of Her2 positive metastatic breast cancer. [J].

Bayo, J ;

Mayordomo, JI ;

Sanchez-Rovira, P ;

Perez-Carrion, R ;

Illaramendi, J ;

Flores, EG ;

Bueno, JMG ;

Vazquez, MR ;

Crespo, C ;

Palomo, AG ;

Huelva, HJRJ .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :67S-67S

[50] Long-term trastuzumab treatment in HER2 positive metastatic breast cancer [J].

Calamac, M. ;

Minic, I. ;

Tomasevic, Z. ;

Oblakovic-Babic, J. ;

Serovic, K. ;

Djurmez, O. ;

Dimitrijevic, M. ;

Bozovic-Spasojevic, I. .

BREAST, 2021, 56 :S82-S83

← 1 2 3 4 5 →